Clinical trial
A Prospective, Multicenter, Single Arm Study to Evaluate the Safety and Effectiveness of Implantation of 'Transcatheter Pulmonary Valve (TPV)' for the Treatment of Congenital Heart Disease With Pulmonary Valve Disease
NCT03110861 is registered in ClinicalTrials.gov with Taewoong Medical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single Arm Study to Evaluate the Safety and Effectiveness of Implantation of 'Transcatheter Pulmonary Valve (TPV)' for the Treatment of Congenital Heart Disease With Pulmonary Valve Disease
- Lead sponsor
- Taewoong Medical Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 22, 2017
- Completion date
- July 12, 2024
- Enrollment
- 15 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart defect, pulmonary valve stenosis, pulmonary valve; insufficiency, congenital